For instance, levels of neurodegenerative biomarkers such as total tau, p-tau181, glial fibrillary acidic protein (GFAP), and neurofilament light (NfL) were increased following COVID-19 infection in patients without a history of neurodegenerative disease (Frontera et al., 2022). This evidence concerns the gene GFAP and neurodegenerative disease.